Work

A Phase I Study of AZD9291 in Patients with Egfr-Tki-Resistant Advanced Nsclc – Updated Progression Free Survival and Duration of Response Data

Year: 2015

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdv128.05

Authors: P.A. Jänne, M.-J. Ahn, D.-W. Kim, S.-W. Kim, D. Planchard, S.S. Ramalingam, P. Frewer, M. Cantarini, S. Ghiorghiu, J.C.-H. Yang

Institutions: Dana-Farber Cancer Institute, Samsung Medical Center, Sungkyunkwan University, Seoul National University Hospital, Asan Medical Center, University of Ulsan, Institut Gustave Roussy, Fondation Gustave Roussy, Emory University, Winship Cancer Institute, AstraZeneca (United Kingdom), National Taiwan University Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W1995720102

FWCI: 3.344

Cites:

Cited by: 18

Related to: 10